Filing metadata

Accession number
0001209191-21-040288
Form type
Form 3
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
Jun 14, 2021
Reporting period
Jun 10, 2021
Description
Initial ownership

Explore SEC Filings Hub